ASCO Genitourinary Cancers Symposium
Playback speed
10 seconds
ASCO GU 2022 TROPHY-U-01 Cohort 3: Sacituzumab Govitecan + Pembrolizumab in mUC After Progression With Platinum-Based Regimens
By
ASCO Genitourinary Cancers Symposium
FEATURING
Petros Grivas
By
ASCO Genitourinary Cancers Symposium
FEATURING
Petros Grivas
108 views
March 8, 2022
Login to view comments.
Click here to Login
Videos